New study demonstrates significant improvements in medication adherence and 6% lower odds of 30-day readmissions at ...

The study analyzed more than 100 million U.S. medical claims from July 1, 2022, through June 30, 2024, and found that nearly one in three eligible heart failure patients are not being treated with ...

By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B of its clinical trial ...

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the final patient has ...

Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

MaineGeneral Health in Augusta had high, rising readmission rates for congestive heart failure. In January 2020, the organization launched a remote patient monitoring pilot, working with vendor Health ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

Congestive heart failure (CHF) affects approximately 4 million individuals in the United States with 500,000 new cases diagnosed each year. [1] Previously, beta-blockers were absolutely ...

The results of the study were presented in a poster presentation this week at the 2003 Heart Failure Society of America Scientific Sessions. "A lot of physicians are very nervous about using ...